Foot-and-Mouth Disease Vaccine Supply Contract
중앙백신
072020
Signal Score
Historical Avg Return (5d)
+0.20%
Data Coverage
100%n=739
Risk-adjusted indicator based on 739 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Contract Amount: 5.81B KRW
- • Percentage of Recent Revenue: 11.85%
- • Contract Period: July 8, 2026 - November 7, 2026
- • Recent Revenue (2025): 49.07B KRW
AI Analysis Summary
CHOONG ANG VACCINE LABORATORY secured a supply contract for SAT1 type Foot-and-Mouth Disease vaccine with the Public Procurement Service, valued at 5.81 billion KRW. This contract represents 11.85% of the company's 2025 revenue of 49.07 billion KRW. The contract period is from July 8, 2026, to November 7, 2026. This is a positive development, contributing to future revenue, although the recognition is in 2026.
How This Event Is Evaluated
Strategic Contract Evaluation
Contract events are evaluated by measuring business scale, revenue relevance, counterparty quality, and execution visibility.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Contract size relative to company revenue
- Expected revenue impact
- Counterparty quality
- Contract duration and execution period
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.